Naresh Daithankar and Shailee Tiwari*
Department of Pharmaceutical Chemistry, Durgamata Institute of Pharmacy, Dharmapuri, Parbhani, India
*Corresponding Author: Shailee Tiwari, Department of Pharmaceutical Chemistry, Durgamata Institute of Pharmacy, Dharmapuri, Parbhani, India.
Received: July 01, 2020; Published: July 28, 2020
In December 2019, the outbreak of the novel coronavirus disease (COVID-19) in China spread worldwide, becoming an emergency of major international concern. The SARS-CoV-2 infection causes a severe respiratory illness similar to severe acute respiratory syndrome coronavirus. Human-to-human transmission via droplets, contaminated hands or surfaces has been described, with incubation times of 2-14 days. This paper reviews the literature on all available information about the diagnosis, prophylaxis, pathophysiology and Current research on COVID-19. Current research on COVID-19 including antimalarial drugs (chloroquine and hydroxychloroquine), antiviral drugs (Ribavirin, remdesivir), antibodies, vaccines and convalescent plasma transfusion, are discussed in this article.
Keywords: COVID-19; Pandemic; Diagnosis; Prophylaxis; Current Research; Remdesivir
Citation: Naresh Daithankar and Shailee Tiwari. “Early Diagnosis, Prophylaxis, Pathophysiology and Current Research On COVID-19". Acta Scientific Pharmaceutical Sciences 4.8 (2020): 107-111.
Copyright: © 2020 Naresh Daithankar and Shailee Tiwari. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.